Oral ingestion of a hydrolyzed gelatin meal in subjects with normal weight and in obese patients: Postprandial effect on circulating gut peptides, glucose and insulin

  • I. G. S. Rubio
  • G. Castro
  • A. C. Zanini
  • G. Medeiros-Neto
Original Research Paper

Abstract

Gut hormones [ghrelin, peptide YY (PYY) and glucagon-like peptide-1 (GLP-1)] are an important group of hormones that target appetite control. They are released from endocrine L cells of the small bowel in proportion to the volume, components and calories in a meal. In the current study, 20 g of gelatin (flavored and sweetened) were given to obese patients (n=12) and lean subjects (n=10). Subsequently, plasma samples were collected at-30-minute intervals up to 180 minutes and glucose, insulin, PYY, GLP-1 and ghrelin were assayed using specific and sensitive immunofluorometric and radioimmunoassays. As expected, obese patients had normal serum glucose levels, higher serum insulin, and lower plasma concentration of ghrelin at all times compared to lean subjects. GLP-1 plasma levels were significantly elevated at 60 minutes, peaking at 120 minutes in obese patients and lean subjects. As a consequence, there was a significant rise in serum insulin levels with a significantly higher peak level at 60 min (obese) and 30 min (lean). There were no significant changes in PYY plasma concentrations and no correlation was found between body mass index and concentrations of ghrelin, PYY and GLP-1 in the group of obese patients. In conclusion, a single gelatin meal induces a rise in plasma GLP-1 followed by an increase in serum levels of insulin. These findings may be applied to maximize satiety in obese patients as a means of improving adherence to calorie-controlled diets as well as provide better control of diabetic patients.

Keywords

Ghrelin GLP-1 PYY insulin glucose gelatin obesity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zimmet P., Alberti K.G., Shaw J.: Global and societal implications of the diabetes epidemic. Nature, 414, 782–787, 2001.CrossRefPubMedGoogle Scholar
  2. 2.
    Bray G.A.: Risks of obesity. Endocrinol. Metab. Clin. North Am., 32, 787–804, 2003.CrossRefPubMedGoogle Scholar
  3. 3.
    Huda M.S.B., Wilding J.P.H., Pinkney J.H.: Gut peptides and the regulation of appetite. Obes. Rev., 7, 163–182, 2006.CrossRefPubMedGoogle Scholar
  4. 4.
    Korner J., Leibel R.L.: To eat or not to eat -how the gut talks to the brain. N. Engl. J. Med., 349, 926–928, 2003.CrossRefPubMedGoogle Scholar
  5. 5.
    Murphy K.G., Dhillo W.S., Bloom S.R.: Gut peptides in the regulation of food intake and energy homeostasis. Endocr. Rev., 27, 719–727, 2006.CrossRefPubMedGoogle Scholar
  6. 6.
    Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., Ghatei M.A., Bloom S.R.: Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med., 349, 941–948, 2003.CrossRefPubMedGoogle Scholar
  7. 7.
    Neary N.M., Small C.J., Druce M.R., Park A.J., Ellis S.M., Senijonous N.M., Dakin C.L., Filipsson K., Wang F., Kent A.S., Frost G.S., Ghatei M.A., Bloom S.R.: Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology, 146, 5120–5127, 2005.CrossRefPubMedGoogle Scholar
  8. 8.
    Verdich C., Flint A., Gutzwiller J.P., Noslund E., Beglinger C., Hellstrom P.M., Long S.J., Morjan L.M., Holst J.J., Astrup A.: A meta-analysis of the effect of glucagon-like peptide-1 (7–36) amide on ad libitum energy intake in humans. J. Clin. Endocrinol. Metab., 86, 4382–4389, 2001.CrossRefPubMedGoogle Scholar
  9. 9.
    Latner J.D., Schwartz M.: The effects of a high-carbohydrate, high-protein or balanced lunch upon later food intake and hunger ratings. Appetite, 33, 119–128, 1999.CrossRefPubMedGoogle Scholar
  10. 10.
    Bowen J., Noakes M., Clifton P.M.: Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake. J. Clin. Endocrinol. Metab., 91, 2913–2919, 2006.CrossRefPubMedGoogle Scholar
  11. 11.
    Bellissimo N., Desantadina M.V., Pencharz P.B., Berall G.B., Thomas S.G., Anderson G.H.: A comparison of short-term appetite and energy intakes in normal weight and obese boys following glucose and whey-protein drinks. Int. J. Obes., Epub. Aug 14, 1–10, 2007.Google Scholar
  12. 12.
    Strader A.D., Woods S.C.: Gastrointestinal hormones and food intake. Gastroenterology, 128, 175–191, 2005.CrossRefPubMedGoogle Scholar
  13. 13.
    van der Lely A.J., Tschop M., Heiman M.L., Ghigo E.: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev., 25, 426–457, 2004.CrossRefPubMedGoogle Scholar
  14. 14.
    Hall W.L., Millward D.J., Long S.J., Morgan L.M.: Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br. J. Nutr., 89, 239–248, 2003.CrossRefPubMedGoogle Scholar
  15. 15.
    Lejeune M.P.G.M., Westerterp K.R., Adam T.C.M., Luscombe-Marsh N.D., Westerterp-Plantenga M.S.: Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber1-3. Am. J. Clin. Nutr., 83, 89–94, 2006.PubMedGoogle Scholar
  16. 16.
    Bowen J., Noakes M., Clifton P.M.: Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages. Int. J. Obes., 31, 1696–1703, 2007.CrossRefGoogle Scholar
  17. 17.
    Velasquez M.T., Bhathena S.J.: Role of dietary soy protein in obesity. Int. J. Med. Sci., 26, 72–82, 2007.CrossRefGoogle Scholar
  18. 18.
    Boirie Y., Dangin M., Gachon P., Vasson M.P., Maubois J.L., Beaufrère B.: Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc. Natl. Acad. Sci., 94, 14930–14935, 1997.CrossRefPubMedGoogle Scholar
  19. 19.
    Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., Purnell J.Q.: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med., 346, 1623–1630, 2002.CrossRefPubMedGoogle Scholar

Copyright information

© Editrice Kurtis 2008

Authors and Affiliations

  • I. G. S. Rubio
    • 1
  • G. Castro
    • 1
  • A. C. Zanini
    • 1
  • G. Medeiros-Neto
    • 1
  1. 1.Department of Internal Medicine and Thyroid Unit (Lim-25)University of São Paulo Medical SchoolSão PauloBrazil

Personalised recommendations